Articles

1861-1880 of 2126 < first | | | last >
  • PAT Success and Speed Hinge on Data Mining

    Not only data mining but metadata must be considered closely, by a cross-functional team representing all users of that data.

    Julio Pamias, CEO, AtlasBITS, Inc.
    06/01/2005
  • Stable Isotopes Find a New Role in PAT

    Used to authenticate products, stable-isotopic analysis can also be used to improve process understanding and control.

    John P. Jasper, Robbe C. Lyon and Larry E. Weaner
    05/31/2005
  • Black Belt Not Required: Do you really know what they want?

    In the words of Dale Carnegie, “You can close more business in two months by becoming interested in other people than you can in two years by trying to get other people interested in you.” Penelope Przekop discusses how to discern and respond to the needs of your internal customers — no matter how difficult they may be.

    Penelope Przekop, MSQA, CQM
    05/20/2005
  • What Patent Owners Should Consider in Filing for a Patent Term Extension

    The Hatch-Waxman Act clarified distortions in patent extension law, but manufacturers still need to tread carefully when considering the extension process. Heidi Kraus of Sterne, Kessler, Goldstein & Fox discusses the four essential points to keep in mind.

    Heidi L. Kraus, Esq., Sterne, Kessler, Goldstein & Fox P.L.L.C.
    05/20/2005
  • Maintenance Management Joins the Party

    Pharmaceutical makers pursue more predictive and global technologies to improve output, ensure compliance.

    Doug Bartholomew, Contributing Editor
    05/12/2005
  • Can 13 Years of FDA Data Teach Us Anything?

    Researchers Jeffrey Macher and Jackson Nickerson are analyzing 13 years of FDA inspection data and reams of documentation to help prioritize inspection risks. We offer their initial findings, presented by Macher at last month’s PDA meeting, as well as the results of Concept Heidelberg’s analysis of 2004 FDA warning letters.

    05/05/2005
  • Powder Blending From Art to Science

    Predictive models, PAT, and continuous processing promise to reduce variability and improve product quality.

    Angelo De Palma, Ph.D., Contributing Editor
    05/05/2005
  • Servos Find a Packaging Niche

    Flexibility is driving more manufacturers to servo-driven packaging lines, but concerns remain about validation and the “blue screen of death” with PC-based controls.

    Alan S. Brown, Contributing Editor
    05/05/2005
  • Career Advice: Get Paid More (Even If You’re Not a Model!)

    Studies by economists show that “above average” looking people tend to earn higher salaries and get promoted more often than those with “average” or “below average” looks.

    JoAnn Hines, PharmaManufacturing.com's Resident Career Expert
    05/05/2005
  • From the Editor: Best Practices or Trade Secrets?

    Security must be a top priority for drug makers, but overly restrictive noncompete and nondisclosure agreements and publishing practices verge on the paranoid – and prevent the exchange of “best practices” that the industry needs in order to improve.

    Agnes Shanley, Editor in Chief
    05/04/2005
  • Events Calendar

    When and where are the key conferences, excellent expos and seminal seminars? Find out here!

    05/02/2005
  • Applying Rapid Microbiological Methods

    Giant steps have been taken towards monitoring microorganisms in manufacturing processes, and doing so quickly. Eli Lilly Senior Research Fellow Michael Miller, Ph.D., discussed them at the recent PDA conference in Chicago. Read more here, then download Miller’s presentation slides.

    04/29/2005
  • Companies Invited to Take Part in a New Proposed Engineering Research Center

    It’s not too soon to get involved in a new Engineering Research Center proposed by Rutgers, Purdue, NJIT and the University of Puerto Rico (Mayaguez). In this article, Rutgers University’s Holly Crawford and Fernando J. Muzzio describe the effort and how corporate involvement early on will help. A meeting is scheduled for May.

    04/29/2005
  • Gain Statistical Control of Your Processes

    One area in which the pharmaceutical industry has been lacking in its approach to PAT and process improvement is in statistical control. In this exclusive interview, Philippe Cini, managing consultant for Tunnell Consulting, offers his thoughts on how the industry can achieve effective quantitative process characterization.

    04/29/2005
1861-1880 of 2126 < first | | | last >